Derivation of two iPSC lines from a sporadic ASD patient (NUIGi033-A) and a paternal control (NUIGi034-A).
Clicks: 307
ID: 97616
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
75.8
/100
305 views
248 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Hundreds of rare risk factors have been identified for ASD, however, the underlying causes for ~70% of sporadic cases are unknown. Sporadic ASD models are thus essential for validating phenotypic commonality and drug suitability to the majority of patients. Here, we derived induced pluripotent stem cells (iPSCs) from one sporadic ASD child and one paternal control, using non-integrating Sendai viral methods. The iPSCs strongly expressed pluripotency markers and could be differentiated into three germ layers. Their normal karyotype was validated by genome SNP array. The availability of sporadic ASD-derived iPSCs offers an opportunity for phenotypic comparison with genetic ASD models.
| Reference Key |
de-la-cruz2020derivationstem
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | de la Cruz, Berta Marcó;Ding, Yicheng;McInerney, Veronica;Krawczyk, Janusz;Lu, Yin;Yang, Guangming;Qian, Xiaohong;Li, Weidong;Howard, Linda;Allen, Nicholas M;O'Brien, Timothy;Gallagher, Louise;Shen, Sanbing; |
| Journal | Stem cell research |
| Year | 2020 |
| DOI |
S1873-5061(20)30026-X
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.